Free E-Newsletter  

Dr. Isaac Eliaz

  • Hot Topics
  • Video Library
  • Research
  • Practitioner Profiles
  • Patient Stories
  • About Us
  • Health Reports
  • Sign Up for E-Newsletter
  • Research Library
  • Links

Research Library

The following scientific abstracts have been reviewed by the Dr. Eliaz staff for relevance to the ingredient Inositol. Click on any of the following abstract titles to see the details of the abstract.

Title: Preventive potential of wheat bran fractions against experimental colon carcinogenesis: implications for human colon cancer prevention.
Authors: Reddy BS; Hirose Y; Cohen LA; Simi B; Cooma I Rao CV
Journal: Cancer Res 2000 Sep 1;60(17):4792-7

Title: Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol.
Authors: Wattenberg LW; Wiedmann TS; Estensen RD Zimmerman CL; Galbraith AR; Steele VE; Kelloff GJ
Journal: Carcinogenesis 2000 Feb;21(2):179-82

Title: Effect of IP6 on human neutrophil cytokine production and cell morphology.
Authors: Eggleton P
Journal: Anticancer Res 1999 Sep-Oct;19(5A):3711-5

Title: Inositol hexaphosphate (IP6) as an anti-neoplastic and lipid-lowering agent.
Authors: Jariwalla RJ
Journal: Anticancer Res 1999 Sep-Oct;19(5A):3699-702

Title: Prevention of colon carcinogenesis by components of dietary fiber.
Authors: Reddy BS
Journal: Anticancer Res 1999 Sep-Oct;19(5A):3681-3

Title: Modifying effects of phytic acid and gamma-oryzanol on the promotion stage of rat carcinogenesis.
Authors: Hirose M; Fukushima S; Imaida K; Ito N; Shirai T
Journal: Anticancer Res 1999 Sep-Oct;19(5A):3665-70

Title: Suppression of lung and liver carcinogenesis in mice by oral administration of myo-inositol.
Authors: Nishino H; Murakoshi M; Masuda M; Tokuda H; Satomi Y Onozuka M; Yamaguchi S; Bu P; Tsuruta A; Nosaka K; Baba M Takasuka N
Journal: Anticancer Res 1999 Sep-Oct;19(5A):3663-4

Title: Chemoprevention of pulmonary carcinogenesis by myo-inositol.
Authors: Wattenberg LW
Journal: Anticancer Res 1999 Sep-Oct;19(5A):3659-61

Title: Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome.
Authors: Nestler JE; Jakubowicz DJ; Reamer P; Gunn RD Allan G
Journal: N Engl J Med 1999 Apr 29;340(17):1314-20

Title: IP6 in treatment of liver cancer. II. Intra-tumoral injection of IP6 regresses pre-existing human liver cancer xenotransplanted in nude mice.
Authors: Vucenik I; Zhang ZS; Shamsuddin AM
Journal: Anticancer Res 1998 Nov-Dec;18(6A):4091-6

Title: IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line.
Authors: Vucenik I; Tantivejkul K; Zhang ZS; Cole KE; Saied I Shamsuddin AM
Journal: Anticancer Res 1998 Nov-Dec;18(6A):4083-90

Title: Suppression of lung and liver carcinogenesis in mice by oral administration of myo-inositol.
Authors: Nishino H; Murakoshi M; Masuda M; Tokuda H; Satomi Y Onozuka M; Yamaguchi S; Bu P; Tsuruta A; Nosaka K; Baba M Takasuka N
Journal: Anticancer Res 1999 Sep-Oct;19(5A):3663-4

Title: Modifying effects of phytic acid and gamma-oryzanol on the promotion stage of rat carcinogenesis.
Authors: Hirose M; Fukushima S; Imaida K; Ito N; Shirai T
Journal: Anticancer Res 1999 Sep-Oct;19(5A):3665-70

Title: Prevention of colon carcinogenesis by components of dietary fiber.
Authors: Reddy BS
Journal: Anticancer Res 1999 Sep-Oct;19(5A):3681-3

Title: Inositol hexaphosphate (IP6) as an anti-neoplastic and lipid-lowering agent.
Authors: Jariwalla RJ
Journal: Anticancer Res 1999 Sep-Oct;19(5A):3699-702

Title: Effect of IP6 on human neutrophil cytokine production and cell morphology.
Authors: Eggleton P
Journal: Anticancer Res 1999 Sep-Oct;19(5A):3711-5

Title: Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol.
Authors: Wattenberg LW; Wiedmann TS; Estensen RD Zimmerman CL; Galbraith AR; Steele VE; Kelloff GJ
Journal: Carcinogenesis 2000 Feb;21(2):179-82

Title: IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line.
Authors: Vucenik I; Tantivejkul K; Zhang ZS; Cole KE; Saied I Shamsuddin AM
Journal: Anticancer Res 1998 Nov-Dec;18(6A):4083-90

Title: IP6 in treatment of liver cancer. II. Intra-tumoral injection of IP6 regresses pre-existing human liver cancer xenotransplanted in nude mice.
Authors: Vucenik I; Zhang ZS; Shamsuddin AM
Journal: Anticancer Res 1998 Nov-Dec;18(6A):4091-6

Title: Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome.
Authors: Nestler JE; Jakubowicz DJ; Reamer P; Gunn RD Allan G
Journal: N Engl J Med 1999 Apr 29;340(17):1314-20

Title: Chemoprevention of pulmonary carcinogenesis by myo-inositol.
Authors: Wattenberg LW
Journal: Anticancer Res 1999 Sep-Oct;19(5A):3659-61

Title: Preventive potential of wheat bran fractions against experimental colon carcinogenesis: implications for human colon cancer prevention.
Authors: Reddy BS; Hirose Y; Cohen LA; Simi B; Cooma I Rao CV
Journal: Cancer Res 2000 Sep 1;60(17):4792-7

Back to Research Library

  • Hot Topics
  •   Video Library
  •   Research
  •   Practitioner Profiles
  •   Patient Stories
  •   About Us

© 2008, Dr. Eliaz

website design by Propeller